101 related articles for article (PubMed ID: 19847809)
1. Letter in response to "Identifying Lynch syndrome" by de la Chapelle et al.
Jenkins MA; Dowty JG; Hopper JL; Tucker K; Southey MC
Int J Cancer; 2010 Jun; 126(11):2757-8. PubMed ID: 19847809
[No Abstract] [Full Text] [Related]
2. Cancer risk assessment in Lynch syndrome: does the gene matter?
Xicola RM; Llor X
JAMA; 2011 Jun; 305(22):2351-2. PubMed ID: 21642691
[No Abstract] [Full Text] [Related]
3. Identifying Lynch syndrome.
de la Chapelle A; Palomaki G; Hampel H
Int J Cancer; 2009 Sep; 125(6):1492-3. PubMed ID: 19536819
[No Abstract] [Full Text] [Related]
4. Molecular screening for Lynch syndrome: from bench to bedside.
Jensen LH; Lindebjerg J; Kølvraa S; Crüger DG
J Clin Oncol; 2009 Dec; 27(34):e224; author reply e225. PubMed ID: 19858372
[No Abstract] [Full Text] [Related]
5. Decoding hereditary colorectal cancer.
Boland CR
N Engl J Med; 2006 Jun; 354(26):2815-7. PubMed ID: 16807419
[No Abstract] [Full Text] [Related]
6. Evaluation and management of Lynch syndrome.
Boland CR
Clin Adv Hematol Oncol; 2007 Nov; 5(11):851,873. PubMed ID: 18185481
[No Abstract] [Full Text] [Related]
7. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
8. The mystery of mismatch repair deficiency: lynch or lynch-like?
Boland CR
Gastroenterology; 2013 May; 144(5):868-70. PubMed ID: 23523847
[No Abstract] [Full Text] [Related]
9. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.
Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK
Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164
[TBL] [Abstract][Full Text] [Related]
10. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
[TBL] [Abstract][Full Text] [Related]
11. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
Alemayehu A; Sebova K; Fridrichova I
Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
[TBL] [Abstract][Full Text] [Related]
12. The hMSH2 and hMLH1 genes in hereditary nonpolyposis colorectal cancer.
Lynch PM
Surg Oncol Clin N Am; 2009 Oct; 18(4):611-24. PubMed ID: 19793569
[TBL] [Abstract][Full Text] [Related]
13. Re: Rahner et al. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome. J Pathol 2008; 214: 10-16.
Lehmann U
J Pathol; 2008 May; 215(1):97; author reply 98. PubMed ID: 18335486
[No Abstract] [Full Text] [Related]
14. Identifying hereditary nonpolyposis colorectal cancer.
Lynch HT; Smyrk TC
N Engl J Med; 1998 May; 338(21):1537-8. PubMed ID: 9593794
[No Abstract] [Full Text] [Related]
15. High frequency of large gene deletions and rearrangements in Lynch syndrome--back to the future?
Eng C
Gastroenterology; 2005 Sep; 129(3):1124-6. PubMed ID: 16143150
[No Abstract] [Full Text] [Related]
16. The three nucleotide deletion within the 3'untranslated region of MLH1 resulting in gene expression reduction is not a causal alteration in Lynch syndrome.
Tinat J; Baert-Desurmont S; Latouche JB; Vasseur S; Martin C; Bouvignies E; Frébourg T
Fam Cancer; 2008; 7(4):339-40. PubMed ID: 18496770
[No Abstract] [Full Text] [Related]
17. The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1.
Krüger S; Engel C; Bier A; Silber AS; Görgens H; Mangold E; Pagenstecher C; Holinski-Feder E; von Knebel Doeberitz M; Royer-Pokora B; Dechant S; Pox C; Rahner N; Müller A; Schackert HK;
Cancer Lett; 2007 Jul; 252(1):55-64. PubMed ID: 17224235
[TBL] [Abstract][Full Text] [Related]
18. [Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
Wullen B; Mühlhöfer A; Zoller WG
Z Gastroenterol; 2001 Nov; 39(11):981-4. PubMed ID: 11778159
[No Abstract] [Full Text] [Related]
19. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
[TBL] [Abstract][Full Text] [Related]
20. Mediating mismatch repair.
Jiricny J
Nat Genet; 2000 Jan; 24(1):6-8. PubMed ID: 10615114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
